new products
digital launch

The long-anticipated Official Launch of the New Generation of PharmaLinea Products finally arrived. This year, it was a digital event and it included a review of new product launch strategy to answer the question: “What should nutraceutical brands launch in time of economic crisis?”. The event was held live on the 3rd of June but you can view the recording and presentation on demand.

what to launch and why now?

In a live broadcast on the 3rd of June, Chairman & Founder of PharmaLinea Blaž Gorjup first discussed new product launch strategy in times of economic crisis. He was followed by Maja Orešnik, our Science & Research director, who revealed 2 new product lines – Pain and Stress – and exciting new developments of {Your} Iron Line.

Key points covered at the event:
  • What can we learn from successful launches from the post-2008 recession?
  • For which product categories do we predict growth in the coming years?
  • First release of entirely new product lines – addressing Pain and Stress
  • Launch of new additions to {Your} Iron Line
  • Presentation of a new promotion tool – a self-testing device for blood iron levels

The highest growth for the next 5 years is expected for Thailand and Vietnam, while the more mature market of South Korea is projected to exhibit less growth. However, the latter is already nearly 4 times the size of the UK market.

indications, forms & plans.

Klopčič went on to add: “The top-performing categories vary significantly from market to market, but the most common to take top positions are immune system, bone health, cognitive health, beauty and other health areas. The latter is a category where we often find products such as the ones addressing iron deficiency, where we are specialists. Our iron line has been in high demand because iron deficiency is typically more problematic in the region and the available solutions often come with drawbacks such as low absorption and side effects.

With markets evolving faster and faster and consumers in Southeast Asia demanding more and more from their supplement user experience, we are increasingly partnering with companies in the region by providing them with supplements in liquids, sachets, sprays, and other user-friendly product forms. Not to dismiss more traditional, yet still successful capsules and tablets.

We are currently working in Vietnam and South Korea and we are in various stages of registration processes in Indonesia, Malaysia, and the Philippines. We have already seen 100% growth in business from Southeast Asia last year and we project the growth to rise to more than 150% with the launch of more products.”

This year we are expecting results of two clinical trials –
on our immunity and iron supplements.

The trials were designed according to gold standards and with them, we plan to fill the gaps in the two segments by providing our clients with clearly differentiated products and clinically proven efficacy. We are also successfully developing business in the region with solutions addressing sleep and prenatal supplementation.

In our view, the only way to get lasting consumer trust is to provide supplements with benefits one can feel and prove.

reach out.

  • Max. file size: 30 MB.

PharmaLinea © 2024